Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Comment by Looneeon Mar 15, 2019 3:13pm
119 Views
Post# 29492993

RE:RE:Richmond facility

RE:RE:Richmond facility
cannhealth wrote:
Loonie I agree with your take. Clearly EMH is focusing on the new Richmond facility as well as Verdelite in Quebec , particularly given the joint partners' in Pure SunFarms intention to expand the sales of the PSF branded MJ for both recreational and medical sales.


Thanks Cannhealth. They have lots coming on line, their total is around 730k sq ft. and they have 40% of PSF for 2019. They can look at D2 say in the last qtr after PSF pkg license in place and other facilities planted, not to mention revenue rolling in. They have funds now to complete Richmond and Quebec so why dilute further at this time for D2? If I am correct, I agree with this approach. I noticed Goldman is buying a lot today, I think they see value here now.
<< Previous
Bullboard Posts
Next >>